DigiPall; a Trial of Digital Patient Reported Outcome and Biomarker Monitoring in Palliative Care
Recruiting
N/A
Interventional Study
Terminal Illness
Terminal Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 382 (estimated)
- Sponsor
- David Blum · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The aim of this study is to test if a system consisting of a wearable device measuring heartbeats and steps, together with daily communication with a chatbot on the smartphone asking the patients about their symptoms and giving tips, can reduce unplanned hospital readmissions and improve well-being in advanced cancer and severely ill patients.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients with established diagnosis of a metastatic cancer/severe illness with limited life expectancy receiving palliative care services
* Estimated life expectancy \<24 months (physician's guess)/ \>3 months
* Karnofsky Index ≥ 50% / ECOG≤ 2
* Aged \>18 years
* Owns and uses…
Contacts